DK0579826T3 - Carbapenemer, der indeholder en carboxysubstitueret phenylgruppe, fremgangsmåder til deres fremstilling, mellemprodukter og - Google Patents

Carbapenemer, der indeholder en carboxysubstitueret phenylgruppe, fremgangsmåder til deres fremstilling, mellemprodukter og

Info

Publication number
DK0579826T3
DK0579826T3 DK93914514T DK93914514T DK0579826T3 DK 0579826 T3 DK0579826 T3 DK 0579826T3 DK 93914514 T DK93914514 T DK 93914514T DK 93914514 T DK93914514 T DK 93914514T DK 0579826 T3 DK0579826 T3 DK 0579826T3
Authority
DK
Denmark
Prior art keywords
carbapenems
intermediates
carboxy
processes
preparation
Prior art date
Application number
DK93914514T
Other languages
English (en)
Inventor
Michael John Betts
Gareth Morse Davies
Michael Lingard Swain
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of DK0579826T3 publication Critical patent/DK0579826T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK93914514T 1992-02-04 1993-02-02 Carbapenemer, der indeholder en carboxysubstitueret phenylgruppe, fremgangsmåder til deres fremstilling, mellemprodukter og DK0579826T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds
PCT/GB1993/000217 WO1993015078A1 (en) 1992-02-04 1993-02-02 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics

Publications (1)

Publication Number Publication Date
DK0579826T3 true DK0579826T3 (da) 1999-07-26

Family

ID=10709764

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93914514T DK0579826T3 (da) 1992-02-04 1993-02-02 Carbapenemer, der indeholder en carboxysubstitueret phenylgruppe, fremgangsmåder til deres fremstilling, mellemprodukter og

Country Status (35)

Country Link
US (7) US5478820A (da)
EP (1) EP0579826B1 (da)
JP (1) JP2730600B2 (da)
KR (1) KR100200986B1 (da)
CN (1) CN1036006C (da)
AP (1) AP398A (da)
AT (1) ATE173262T1 (da)
AU (1) AU668133B2 (da)
CA (1) CA2106370C (da)
CZ (1) CZ286878B6 (da)
DE (2) DE69322007T2 (da)
DK (1) DK0579826T3 (da)
ES (1) ES2123654T3 (da)
FI (1) FI104074B (da)
GB (2) GB9202298D0 (da)
GE (1) GEP20022694B (da)
HK (1) HK1013998A1 (da)
HR (1) HRP930103B1 (da)
HU (3) HUT66514A (da)
IL (1) IL104588A (da)
LU (1) LU90970I2 (da)
MY (1) MY111685A (da)
NL (1) NL300104I2 (da)
NO (2) NO304315B1 (da)
NZ (2) NZ272038A (da)
PL (3) PL174936B1 (da)
RU (1) RU2117659C1 (da)
SG (1) SG48817A1 (da)
SI (1) SI9300056B (da)
SK (1) SK280890B6 (da)
TW (1) TW408124B (da)
UA (1) UA44885C2 (da)
WO (1) WO1993015078A1 (da)
YU (1) YU48998B (da)
ZA (1) ZA93453B (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
GB9515975D0 (en) * 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
TW513430B (en) * 1996-07-12 2002-12-11 Merck & Co Inc Process for synthesizing carbapenem antibiotics
AU4020897A (en) 1996-08-17 1998-03-06 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
CA2266701C (en) * 1996-10-10 2002-12-24 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
US5877328A (en) * 1996-10-10 1999-03-02 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
CA2268820A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
CA2293835C (en) * 1997-06-16 2003-09-16 John M. Williams Stabilized carbapenem intermediates and synthetic use
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
CA2294341C (en) * 1997-07-10 2007-09-25 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
DE69930616T2 (de) * 1998-03-02 2006-11-23 Merck & Co., Inc. Verfahren zur synthese von carbapenem-antibiotika
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
EP1104424B1 (en) 1998-06-17 2004-04-07 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates
US6486150B2 (en) 1999-10-29 2002-11-26 Merck & Co., Inc. Process for formulation of antibiotic compounds
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
US7022841B2 (en) * 2001-09-26 2006-04-04 Merck & Co. Inc. Process for making carbapenem compounds
US7145002B2 (en) 2001-09-26 2006-12-05 Merck & Co. Inc. Crystalline forms of carbapenem antibiotics and methods of preparation
WO2003072015A2 (en) * 2001-11-08 2003-09-04 Merck & Co., Inc. Compounds useful in the treatment of anthrax
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
NZ536189A (en) * 2002-05-29 2007-08-31 Merck & Co Inc Methylphenylsulfonyl amide derivative compounds useful in the treatment of anthrax and inhibiting lethal factor
US7845870B2 (en) * 2004-05-07 2010-12-07 Infinum Labs, Inc. Multi-position multi-level user interface system
EP1747212A4 (en) * 2004-05-11 2009-03-25 Merck & Co Inc PROCESS FOR PRODUCING N-SULFINATED AMINO ACID DERIVATIVES
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)－1－(4－硝基苄氧羰基)－2－[(3－烯丙氧羰基)－苯基氨基甲酰基]－吡咯烷－4－基硫醇的制备方法
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
DK2484680T3 (da) 2005-12-07 2013-09-08 Basilea Pharmaceutica Ag Nyttige kombinationer af monolactam-antibiotika med beta-lactamase-inhibitorer
WO2008062279A2 (en) * 2006-11-20 2008-05-29 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of carbapenem antibiotic
CN101357916B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有二氢咪唑甲酰胺基的培南化合物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
CN101362761B (zh) * 2007-08-12 2011-05-18 山东轩竹医药科技有限公司 含有巯基哌啶的碳代青霉烯抗生素
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
CN101376641B (zh) * 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
EP2505190A1 (en) 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphic forms of ertapenem monosodium salt and process for it's preparation
CA2732619A1 (en) * 2008-07-30 2010-02-04 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
BRPI0913709A2 (pt) * 2008-09-18 2015-10-13 Manu Chaudhary "formulação farmacêutica"
EP2426131B1 (en) 2009-04-30 2016-08-17 CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Intermediates of carbapenem, compositions containing them and preparation methods thereof
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8729260B2 (en) 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) * 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
AU2013328585A1 (en) * 2012-10-12 2015-04-09 Sandoz Ag Preparation of ertapenem intermediates
CA2906689A1 (en) 2013-03-15 2014-09-18 Kala Pharmaceuticals, Inc. Meropenem derivatives and uses thereof
IN2013MU03862A (da) 2013-12-11 2015-07-31 Unimark Remedies Ltd
MA43791A (fr) * 2016-03-16 2018-11-28 Merck Sharp & Dohme Composés de carbapénème
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺
CN110698480B (zh) * 2018-07-09 2023-09-08 武汉启瑞药业有限公司 一种厄他培南中间体的合成及纯化方法
MX2021008937A (es) * 2019-01-23 2021-11-12 Glycolysis Biomed Co Ltd Compuestos de beta-lactama o sales de los mismos para su uso en la prevencion o tratamiento de accion prolongada del trastorno del metabolismo de la glucosa.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
EP0182213B1 (en) * 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
EP0243686B1 (en) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production
US4974544A (en) * 1986-10-07 1990-12-04 Ricoh Company, Co. Vapor deposition apparatus
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
AU651887B2 (en) * 1991-06-04 1994-08-04 Sankyo Company Limited 1-methylcarbapenem derivatives, their preparation and their use as antibiotics
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2106141A1 (en) * 1992-09-28 1994-03-29 Michael J. Betts Antibiotic compounds

Also Published As

Publication number Publication date
US7041836B2 (en) 2006-05-09
NZ246917A (en) 1995-09-26
NO2002010I2 (no) 2005-03-11
CZ286878B6 (en) 2000-07-12
WO1993015078A1 (en) 1993-08-05
AU3457493A (en) 1993-09-01
NO933530D0 (no) 1993-10-01
GB9202298D0 (en) 1992-03-18
HK1013998A1 (en) 1999-09-17
FI930474A (fi) 1993-08-05
JP2730600B2 (ja) 1998-03-25
PL174936B1 (pl) 1998-10-30
HU213675B (en) 1997-09-29
AP398A (en) 1995-08-29
CA2106370C (en) 2003-11-25
NO2002010I1 (no) 2002-10-09
RU2117659C1 (ru) 1998-08-20
AU668133B2 (en) 1996-04-26
US5478820A (en) 1995-12-26
HU9302777D0 (en) 1993-12-28
NO304315B1 (no) 1998-11-30
HU211840A9 (en) 1995-12-28
US20020042408A1 (en) 2002-04-11
US5652233A (en) 1997-07-29
YU5493A (sh) 1996-05-20
ATE173262T1 (de) 1998-11-15
DE69322007T2 (de) 1999-04-01
SI9300056B (sl) 2000-02-29
DE69322007D1 (de) 1998-12-17
US20030144264A1 (en) 2003-07-31
DE10299041I1 (de) 2003-02-20
SI9300056A (en) 1993-09-30
NO933530L (no) 1993-10-04
US6521612B2 (en) 2003-02-18
NL300104I2 (nl) 2003-02-03
NZ272038A (en) 1997-07-27
EP0579826B1 (en) 1998-11-11
PL174601B1 (pl) 1998-08-31
CN1079224A (zh) 1993-12-08
JPH06506704A (ja) 1994-07-28
SK106393A3 (en) 1994-04-06
NL300104I1 (nl) 2002-12-02
GB9300456D0 (en) 1993-03-03
IL104588A (en) 1999-03-12
TW408124B (en) 2000-10-11
ZA93453B (en) 1993-08-05
YU48998B (sh) 2003-04-30
SG48817A1 (en) 1998-05-18
FI104074B1 (fi) 1999-11-15
HRP930103B1 (en) 1999-12-31
CN1036006C (zh) 1997-10-01
LU90970I2 (fr) 2002-12-09
US20050209212A1 (en) 2005-09-22
FI930474A0 (fi) 1993-02-03
ES2123654T3 (es) 1999-01-16
MY111685A (en) 2000-11-30
UA44885C2 (uk) 2002-03-15
CA2106370A1 (en) 1993-08-05
DE10299041I2 (de) 2003-06-12
AP9300480A0 (en) 1993-01-31
KR100200986B1 (ko) 1999-06-15
GEP20022694B (en) 2002-05-10
FI104074B (fi) 1999-11-15
SK280890B6 (sk) 2000-09-12
PL174649B1 (pl) 1998-08-31
HRP930103A2 (en) 1994-12-31
CZ206793A3 (en) 1994-04-13
EP0579826A1 (en) 1994-01-26
HUT66514A (en) 1994-12-28
US5856321A (en) 1999-01-05
US7342005B2 (en) 2008-03-11
HUT64764A (en) 1994-02-28
US6187804B1 (en) 2001-02-13
IL104588A0 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
DK0579826T3 (da) Carbapenemer, der indeholder en carboxysubstitueret phenylgruppe, fremgangsmåder til deres fremstilling, mellemprodukter og
BR9304861A (pt) Sargento
DK0601965T3 (da) Fremgangsmåde til fremstilling af en forskydningsform-grundmasse
DK0631705T3 (da) Fremgangsmåde til gruppering af forbindelser i en pakkekobler
DK106191A (da) Mellemprodukter til fremstilling af penemer og carbapenemer
DE69302941D1 (de) Fäulnisverhindernde Materialien
DK0793645T3 (da) Iminooxymethylenanilider, fremgangsmåder og mellemprodukter til deres fremstilling, samt pesticider, der indeholder dem
ITUD920118A0 (it) Gruppo avvolgitore-svolgitore per bramme sottili
DK155039C (da) Hjoernebeskytter til emballering af for eksempel glasplader
AU567345B2 (en) 2, 4-dihydro-5-((substituted) phenyl)-4, 4-disubstituted- 3h-pyrazol-3-ones
DE69307943D1 (de) Polyisocyanatzusammensetzung
DK207987D0 (da) Anlaeg til rengoering ved hjaelp af sugning
NO952175D0 (no) Nukleotidsekvens som koder for karbamoylfosfatsyntetitase II
NO932087L (no) Avstandsstykke for armeringselementer
DK366985D0 (da) Fremgangsmaade til deaktivering af en zeolit
NO177395C (no) Modulsystem for bygningsfasader
ITMI920901A1 (it) Gene inducibile da citochine
ATA87692A (de) Ziegel-überlage
DE69307629D1 (de) Farbbandsubstrat
BR7301095U (pt) Espacador modular multi-trava para tijolos
IT231068Y1 (it) Stampo per piastrelle ceramiche.
FI920014A0 (fi) Välike-elin
FI531U1 (fi) Grund foer en pelare
KR940012770U (ko) 거푸집 간격 유지구
KR940003609U (ko) 거푸집 간격 유지구